🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mark Lawler

Queen's University Belfast

ORCID: 0000-0002-3930-8470
MedicineBiochemistry, Genetics and Molecular BiologyEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
4.9Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer

Nature Genetics(2020)10.1038/s41588-020-0603-8
Top 4%
4.9DataRank
Top 4%178 citations

Brian Walsh, Georgia Mayfield, David Tamborero, Dmitriy Sonkin, Kilannin Krysiak +34 more

Papers

Driven by 7 papers — median percentile 96. Top paper: “A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer”.

A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer

Nature Genetics(2020)10.1038/s41588-020-0603-8
Top 4%
4.9DataRank
Top 4%178 citations

Brian Walsh, Georgia Mayfield, David Tamborero, Dmitriy Sonkin, Kilannin Krysiak +34 more

Evidence generation and reproducibility in cell and gene therapy research: A call to action

Molecular Therapy - Methods & Clinical Development(2021)10.1016/j.omtm.2021.06.012
N/A
0.934DataRank · unranked
24 citations

Aris Angelis, Frederick R. Appelbaum, Nancy C. Andrews, Susan E. Bates, Arlene S. Bierman +33 more

Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features

Nature Communications(2022)10.1038/s41467-022-35134-3
N/A
0DataRank · unranked
17 citations

Raheleh Amirkhah, David F. Vincent, Nuray Gündüz, Pauline Gentaz, Patrizia Cammareri +34 more

surviveR: a flexible shiny application for patient survival analysis

Scientific Reports(2023)10.1038/s41598-023-48894-9
N/A
0DataRank · unranked
13 citations

Gerard P. Quinn, Mark Wappett, Emily Rogan, David J. Sharkey, Baharak Ahmaderaghi +4 more

A new war on cancer?

The Lancet Oncology(2025)10.1016/s1470-2045(25)00134-2
N/A
0DataRank · unranked
4 citations

Richard Sullivan, Mark Lawler

Stratification of Chemotherapy-Treated Stage III Colorectal Cancer Patients Using Multiplexed Imaging and Single Cell Analysis of T Cell Populations

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.24.432210
N/A
0DataRank · unranked
3 citations

Maurice B. Loughrey, Manuela Salvucci, Andreas U. Lindner, Sanghee Cho, Elizabeth McDonough +12 more

Stratification of chemotherapy-treated stage III colorectal cancer patients using multiplexed imaging and single-cell analysis of T-cell populations

Modern Pathology(2021)10.1038/s41379-021-00953-0
N/A
0DataRank · unranked
24 citations

Maurice B. Loughrey, Manuela Salvucci, Andreas U. Lindner, Sanghee Cho, Elizabeth McDonough +15 more